-->

Videos & Press

Videos & Press

These pages contain ever-growing lists of interactions between the physicians who developed the MATH+ protocol with media, health care, and governmental organizations, including: Senate sub-committee testimony, speaker panel discussions with medical organizations, interviews on radio, television, and internet-based programs, as well as articles published in magazines and journals about the FLCCC Alliance. You’ll also find recent newspaper, TV, and radio news reports about the members’ success in treating COVID-19 patients with MATH+ in their hospitals.

Please regard our steadily updated video sections:  Videos & Tutorials and our  Weekly Update Archive.

Selected videos

Global Medical & Scientific Experts Call Upon World Governments to Act Now to Save Lives (March 19, 2021)

At a March 18, 2021 press conference, a group of medical and scientific experts convened by the Front Line COVID-19 Critical Care Alliance (FLCCC) called for action to put an end to the COVID-19 pandemic by immediately adopting policies that allow for the use of ivermectin in the prevention and treatment of COVID-19.

Scientists and physicians from the US, UK, EU, South America, and Israel gathered to discuss the latest data on how ivermectin has reduced positive COVID-19 cases in major cities across the world, ivermectin’s role in the early treatment of COVID-19, and why ivermectin needs to be adopted as safe and effective prevention and treatment of COVID-19.

How the FLCCC Alliance came together and developed effective treatment protocols for COVID-19 (March 10, 2021)

This is the story about how the FLCCC Alliance was formed—and how, at the start of the pandemic, the team quickly began to develop protocols to successfully treat patients. Their first protocol was the MATH+ Hospital Treatment Protocol that was used to save critically ill patients and to prevent them from having to rely on ventilators to breathe. Subsequently, as COVID-19 cases surged, they urgently researched ways to offload the hospitals and reduce case counts and deaths. The team developed the I-MASK+ Prevention & Early Outpatient Treatment Protocol—centered around the drug ivermectin—which is effective for every phase of COVID-19 disease… from prevention through late phase illness.

Black, Brown and Elderly People—Addressing the Disproportionate Incidence of COVID-19 (Feb 8, 2021)

The large discrepancy in the number of black, brown and elderly people contracting COVID-19 or succumbing to the disease must be urgently addressed. The FLCCC Alliance is recommending the urgent adoption of the I-MASK+ Protocol based on ivermectin for the prevention and treatment of COVID-19. The protocol is a safe, readily available and inexpensive way to keep these populations safe while waiting for the vaccine.

The FLCCC Alliance – On a mission to Save Thousands & Slow the Pandemic (A brief self-introduction; Jan 19, 2021)

Read More


Beyond The Roundup | Fact Checking The Fact Checkers: Associated Press VS Ivermectin (Dec 19, 2020)

Fact Checking the Fact Checkers – The Case of Ivermectin for Publicly-Subsidized Research: On December 11, TrialSite News reported on a US Senate hearing at which, among other things, there was testimony urgently calling for more research and an EUA for ivermectin as both a prophylactic against and an early treatment for COVID-19.

Read More

Dr. Pierre Kory (FLCCC Alliance) testifies to senate committee about I-MASK+ (incl. Q & A) (Dec 8, 2020; Vimeo)

The ‘NewsNOW’ feed of Dr. Kory’s impressive testimony had 5 million views on Youtube within the first 10 days (after 6 weeks deleted by Youtube, like our own YT version before)

Summary:

Read More

What you can do to prevent getting COVID-19 (Dec 3, 2020)

Dr. Paul Marik, a founding member of the Front Line COVID-19 Critical Care Alliance, takes you through all of the steps you can take to keep from getting COVID-19. At the heart of it is the FLCCC Alliance’s I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol. Its components include ivermectin, shown in study after study to prevent COVID-19 and to keep patients who become symptomatic from progressing into more serious COVID-19 illness.